Skip to content

My Pathway to Healing

My Pathway to Healing: Adaptation and Testing of a Common Elements Treatment Approach to Address Trauma, Suicide Ideation and Substance Abuse

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04585906
Acronym
MP2H
Enrollment
36
Registered
2020-10-14
Start date
2022-07-19
Completion date
2024-11-12
Last updated
2025-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suicide; Trauma, Binge Drinking

Brief summary

The goal of this project is to test the feasibility and acceptability of a common elements intervention delivered by community mental health workers for adults with a history of adverse childhood experiences. Common elements interventions build cognitive, emotional, interpersonal, and behavioral skills to help address trauma-related distress and build resilience. This will be accomplished using a randomized control trial with Apache adults ages 25-65 with recent suicidal behaviors, self-injurious behaviors, and/or binge substance use.

Detailed description

This is a mixed-methods study with qualitative data informing adaptation and evaluation of a common elements intervention delivered by community mental health specialists, named My Pathway to Healing. The study includes a pilot trial and CAB discussions to inform our understanding of the feasibility of scaling up the intervention. The investigators randomized some participants to receive the interventions and some to receive control case manager visits, to pilot what a future effectiveness RCT might be. This intervention integrates psychoeducation, relaxation techniques, problem solving and cognitive coping, and addresses safety (when identified as a problem area). The intervention used in the intervention arm of our study has been developed for the specific context and culture of White Mountain Apache. Those randomized into the My Pathway to Healing group will receive 4-8 hour-long sessions with a community mental health specialist, taking place over 8-12 weeks. The exact number of sessions will depend on presentation and symptom level using a stepped care approach where participants receive only what they need, but the provider can provide additional sessions if needed (i.e., increased element dosage; additional optional elements for specific issues). Those randomized into the control will continue to receive the standard case management via the Apache surveillance system. These control participants will be offered the My Pathway to Healing Program upon completion of the study. Participants will be asked to partake in 5 study assessments. For intervention participants these assessments will take place at: baseline, after their last intervention session (endline; approximately 8-12 weeks post-baseline) and 4, 8, and 12 weeks post-endline. For control participants, these assessments will take place at: baseline, 8-12 weeks post-baseline (the maximum time the intervention would last; will be referred to as an endline) and 4, 8 and 12 weeks post-endline. These assessment visits will be conducted by Research Program Assistants. Assessments will take approximately 45-90 minutes to complete. In the feasibility study, assessments are not being statistically analyzed.

Interventions

The intervention integrates psychoeducation and addresses safety (when identified as a problem area). It also includes relaxation techniques, problem solving, and cognitive coping.

Sponsors

Native American Research Center for Health
CollaboratorOTHER
National Institute of General Medical Sciences (NIGMS)
CollaboratorNIH
Johns Hopkins Bloomberg School of Public Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Investigators will use a randomized control design.

Eligibility

Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 25-65 * Suicide ideation, suicide attempt, self-injurious behavior, and/or binge alcohol and/or drug use within past 90 days confirmed by the Apache suicide surveillance system * Experienced at least 2 adverse childhood experiences * Native American * Reside on or near the Fort Apache Indian Reservation. * An average score of 1 or above on a measure of symptoms of posttraumatic stress

Exclusion criteria

* Unable to provide informed consent * Have a serious developmental disorder * Have active psychosis

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Completing VisitsUp to 12 weeks post-baselineFeasibility as assessed by the number of participants completing sessions; 0, 0% reflects lowest feasibility, 100% reflects highest feasibility.
Number of People Approached Who Consented or DeclinedAt consentThis timepoint is pre-randomization. 68 potential participants were approached to join the study; feasible if those who decline participation is less than 20%, a lower decline percentage indicates greater feasibility. A higher consent percentage indicates greater feasibility.

Countries

United States

Participant flow

Pre-assignment details

The study consented n=36 adults, then n=5 were lost to followup (LTFU) before baseline assessment; n=31 completed baseline assessment and were randomized.

Participants by arm

ArmCount
Sessions With a Community Mental Health Specialist
Those randomized into the intervention group will receive 4-8 hour-long sessions with a community mental health specialist, taking place over approximately 12 weeks. The common elements treatment approach intervention (called My Pathway to Healing) includes psychoeducation and addresses safety (when identified as a problem area). It also includes relaxation techniques, problem solving, and cognitive coping. The exact number of sessions delivered will depend on presentation and symptom level using a stepped care approach where participants receive only what they need, but the provider can provide additional sessions if needed (i.e., increased element dosage; additional optional elements for specific issues). Common Elements Treatment Approach: The intervention integrates psychoeducation and addresses safety (when identified as a problem area). It also includes relaxation techniques, problem solving, and cognitive coping.
15
Case Management
This study employs a randomized control design in which participants in the control group will receive case management and offered the intervention upon completion of their enrollment period. Common Elements Treatment Approach: The intervention integrates psychoeducation and addresses safety (when identified as a problem area). It also includes relaxation techniques, problem solving, and cognitive coping.
16
Total31

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up85

Baseline characteristics

CharacteristicSessions With a Community Mental Health SpecialistCase ManagementTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
15 Participants16 Participants31 Participants
Index event behavior
Binge substance use
5 Participants8 Participants13 Participants
Index event behavior
Self-injury
1 Participants1 Participants2 Participants
Index event behavior
Suicide attempt
2 Participants1 Participants3 Participants
Index event behavior
Suicide ideation
7 Participants6 Participants13 Participants
Race (NIH/OMB)
American Indian or Alaska Native
15 Participants16 Participants31 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
United States
15 Participants16 Participants31 Participants
Sex: Female, Male
Female
7 Participants4 Participants11 Participants
Sex: Female, Male
Male
8 Participants12 Participants20 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 150 / 16
other
Total, other adverse events
1 / 152 / 16
serious
Total, serious adverse events
0 / 150 / 16

Outcome results

Primary

Number of Participants Completing Visits

Feasibility as assessed by the number of participants completing sessions; 0, 0% reflects lowest feasibility, 100% reflects highest feasibility.

Time frame: Up to 12 weeks post-baseline

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Sessions With a Community Mental Health SpecialistNumber of Participants Completing Visits7 Participants
Case ManagementNumber of Participants Completing Visits11 Participants
Primary

Number of People Approached Who Consented or Declined

This timepoint is pre-randomization. 68 potential participants were approached to join the study; feasible if those who decline participation is less than 20%, a lower decline percentage indicates greater feasibility. A higher consent percentage indicates greater feasibility.

Time frame: At consent

Population: Potential participants approached

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Sessions With a Community Mental Health SpecialistNumber of People Approached Who Consented or Declined32 Participants
Case ManagementNumber of People Approached Who Consented or Declined36 Participants

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026